|
Parmax Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
13.38 Cr.
|
P/BV
|
-4.96
|
Book Value (Rs.)
|
-7.21
|
|
52 Week High/Low (Rs.)
|
55/32
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -5.60 | -11.33 | -0.28 | 0.38 | 2.02 |
| Diluted EPS (Rs.) | -5.60 | -11.33 | -0.28 | 0.38 | 2.02 |
| Cash EPS (Rs.) | -2.39 | -9.14 | 3.99 | 4.66 | 6.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -4.47 | 0.15 | 13.15 | 13.38 | 13.07 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -4.47 | 0.15 | 13.15 | 13.38 | 13.07 |
| Revenue From Operations / Share (Rs.) | 63.36 | 24.83 | 34.65 | 41.00 | 58.87 |
| PBDIT / Share (Rs.) | 0.66 | -7.46 | 5.15 | 5.89 | 7.87 |
| PBIT / Share (Rs.) | -1.66 | -11.31 | 0.93 | 1.55 | 3.51 |
| PBT / Share (Rs.) | -5.38 | -12.71 | 0.10 | 0.68 | 2.71 |
| Net Profit / Share (Rs.) | -4.70 | -12.98 | -0.23 | 0.31 | 1.69 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 1.04 | -30.05 | 14.87 | 14.36 | 13.37 |
| PBIT Margin (%) | -2.61 | -45.54 | 2.69 | 3.77 | 5.96 |
| PBT Margin (%) | -8.49 | -51.17 | 0.29 | 1.66 | 4.61 |
| Net Profit Margin (%) | -7.42 | -52.28 | -0.67 | 0.77 | 2.87 |
| Return on Networth / Equity (%) | 0.00 | -8146.36 | -1.77 | 2.37 | 12.96 |
| Return on Capital Employeed (%) | -12.90 | -82.27 | 3.96 | 6.46 | 13.60 |
| Return On Assets (%) | -11.16 | -37.69 | -0.59 | 0.78 | 3.31 |
| Long Term Debt / Equity (X) | -3.87 | 83.26 | 0.76 | 0.75 | 0.93 |
| Total Debt / Equity (X) | -3.87 | 83.26 | 0.76 | 0.75 | 0.93 |
| Asset Turnover Ratio (%) | 1.66 | 0.67 | 0.86 | 0.89 | 1.20 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.76 | 0.62 | 1.05 | 0.89 | 0.91 |
| Quick Ratio (X) | 0.51 | 0.36 | 0.45 | 0.50 | 0.56 |
| Inventory Turnover Ratio (X) | 7.54 | 2.10 | 1.54 | 1.97 | 4.02 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.50 | -5.34 | 6.22 | 6.79 | 9.89 |
| Interest Coverage Ratio (Post Tax) (%) | -0.74 | -8.30 | 0.71 | 1.37 | 3.13 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 23.42 | 18.53 | 17.59 | 21.65 | 18.69 |
| EV / Net Operating Revenue (X) | 0.93 | 1.68 | 1.14 | 1.19 | 0.71 |
| EV / EBITDA (X) | 89.79 | -5.58 | 7.67 | 8.26 | 5.33 |
| MarketCap / Net Operating Revenue (X) | 0.66 | 1.15 | 0.87 | 0.99 | 0.60 |
| Price / BV (X) | -9.46 | 179.12 | 2.31 | 3.05 | 2.72 |
| Price / Net Operating Revenue (X) | 0.66 | 1.15 | 0.87 | 0.99 | 0.60 |
| EarningsYield | -0.11 | -0.45 | -0.01 | 0.01 | 0.04 |
